{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:11:56Z","timestamp":1779275516426,"version":"3.51.4"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"abstract":"<jats:p>Metabolic dysfunction-associated fatty liver disease (MAFLD) is linked to specific multisystem disorders. These include kidney-related diseases, which have a serious impact on patients\u2019 quality of life. While UACR (urinary albumin-to-creatinine ratio) is one of the indicators for assessing renal function, examining its connection with MAFLD can aid in understanding MAFLD\u2019s pathophysiology and non-liver-related complications. Cross-sectional surveys utilized data from the National Health and Nutrition Examination Survey between 2017 and 2020. The linear relationship between UACR and controlled attenuation parameters (CAP) was analyzed using multiple linear regression models, and a fitting smoothing curve was additionally applied to explore this connection. This population-based study examined 5506 nondiabetic adults aged 18 and older, finding that 38.45% had MAFLD. Higher UACR quartiles were associated with increased CAP and MAFLD prevalence. After adjustments, a positive link was seen between UACR, CAP, and MAFLD (\u03b2\u2005=\u20055.09, 95% CI: 2.72\u20137.46; OR\u2005=\u20051.14, 95% CI: 1.00\u20131.29). Compared to the UACR lowest quartile group (OR\u2005=\u20051.14, 95% CI: 1.00\u20131.29), the highest quartile group had a 7.08-unit higher CAP (\u03b2\u2005=\u20057.08, 95% CI: 3.78\u201310.78), and a 14% higher risk of developing MAFLD. Subgroup analysis revealed significant racial differences in these associations. UACR was linked to higher CAP values and a greater risk of MAFLD. Further large-scale, prospective studies are required to validate our results.<\/jats:p>","DOI":"10.1097\/md.0000000000045270","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:02:18Z","timestamp":1763571738000},"page":"e45270","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association between urinary albumin-to-creatinine ratio and metabolic dysfunction-associated fatty liver disease in individuals without diabetes mellitus"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2840-4081","authenticated-orcid":false,"given":"Qi","family":"Jia","sequence":"first","affiliation":[{"name":"School of Medicine, Yan\u2019an University, Yan\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liting","family":"Hao","sequence":"additional","affiliation":[{"name":"School of Medicine, Yan\u2019an University, Yan\u2019an, China"},{"name":"Department of Gastroenterology, Affiliated Hospital of Yan\u2019an University, Yan\u2019an, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimi","family":"Qiang","sequence":"additional","affiliation":[{"name":"School of Medicine, Yan\u2019an University, Yan\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[{"name":"School of Medicine, Yan\u2019an University, Yan\u2019an, China"},{"name":"Department of Gastroenterology, Affiliated Hospital of Yan\u2019an University, Yan\u2019an, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Medicine, Yan\u2019an University, Yan\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[{"name":"School of Medicine, Yan\u2019an University, Yan\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuying","family":"Bu","sequence":"additional","affiliation":[{"name":"School of Medicine, Yan\u2019an University, Yan\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cunying","family":"Meng","sequence":"additional","affiliation":[{"name":"School of Medicine, Yan\u2019an University, Yan\u2019an, China"},{"name":"Department of Gastroenterology, Affiliated Hospital of Yan\u2019an University, Yan\u2019an, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260520","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S2468-1253(22)00008-5","article-title":"The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas.","volume":"7","author":"D\u00edaz","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis.","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S2468-1253(21)00100-X","article-title":"Racial and ethnic disparities in non-alcoholic fatty liver disease in the USA.","volume":"6","author":"Rich","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R4-20260520","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases.","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"R6-20260520","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1464-5491.2005.01582.x","article-title":"Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults.","volume":"22","author":"Jimba","year":"2005","journal-title":"Diabet Med"},{"key":"R7-20260520","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","article-title":"Global liver disease burdens and research trends: analysis from a Chinese perspective.","volume":"71","author":"Xiao","year":"2019","journal-title":"J Hepatol"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease.","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"R9-20260520","doi-asserted-by":"crossref","first-page":"100219","DOI":"10.1016\/j.jhepr.2020.100219","article-title":"Case-finding strategies in non-alcoholic fatty liver disease.","volume":"3","author":"Boursier","year":"2020","journal-title":"JHEP Rep"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease.","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2337\/dc20-1778","article-title":"High prevalence of advanced liver fibrosis assessed by transient elastography among U.S. adults with type 2 diabetes.","volume":"44","author":"Ciardullo","year":"2021","journal-title":"Diabetes Care"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"62","DOI":"10.47102\/annals-acadmedsg.V29N1p62","article-title":"Evaluation of a rapid screening test for microalbuminuria with a spot measurement of urine albumin\u2013creatinine ratio.","volume":"29","author":"Ng","year":"2000","journal-title":"Ann Acad Med Singap"},{"key":"R13-20260520","first-page":"1","article-title":"Burden, access, and disparities in kidney disease.","volume":"13","author":"Crews","year":"2019","journal-title":"Iran J Kidney Dis"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","article-title":"KDIGO 2021 Clinical Practice Guideline for the management of blood pressure in chronic kidney disease.","volume":"99","year":"2021","journal-title":"Kidney Int"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/HJH.0000000000000809","article-title":"Low-grade albuminuria and incidence of cardiovascular disease and all-cause mortality in nondiabetic and normotensive individuals.","volume":"34","author":"Tanaka","year":"2016","journal-title":"J Hypertens"},{"key":"R16-20260520","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4093\/dmj.2017.41.6.430","article-title":"Non-alcoholic fatty liver disease: the emerging burden in cardiometabolic and renal diseases.","volume":"41","author":"Han","year":"2017","journal-title":"Diabetes Metab J"},{"key":"R17-20260520","first-page":"9583790","article-title":"Nonalcoholic fatty liver disease aggravated the severity of acute pancreatitis in patients.","volume":"2019","author":"Wu","year":"2019","journal-title":"Biomed Res Int"},{"key":"R18-20260520","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2014.05.019","article-title":"CKD and nonalcoholic fatty liver disease.","volume":"64","author":"Targher","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R19-20260520","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.metabol.2017.11.003","article-title":"Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis.","volume":"79","author":"Mantovani","year":"2018","journal-title":"Metabolism"},{"key":"R20-20260520","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/liv.14419","article-title":"PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: clinical and experimental findings.","volume":"40","author":"Mantovani","year":"2020","journal-title":"Liver Int"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/liv.14251","article-title":"PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels.","volume":"40","author":"Sun","year":"2020","journal-title":"Liver Int"},{"key":"R22-20260520","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/liv.14125","article-title":"Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: a secondary analysis.","volume":"39","author":"Wilechansky","year":"2019","journal-title":"Liver Int"},{"key":"R23-20260520","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/qjmed\/hcw070","article-title":"Nonalcoholic fatty liver disease is associated with low-grade albuminuria in Chinese adults (change not displayed).","volume":"109","author":"Lin","year":"2016","journal-title":"QJM"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1681\/ASN.2007101155","article-title":"Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease.","volume":"19","author":"Targher","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R25-20260520","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.metabol.2007.11.022","article-title":"Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men.","volume":"57","author":"Chang","year":"2008","journal-title":"Metabolism"},{"key":"R26-20260520","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2169\/internalmedicine.50.5043","article-title":"The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease.","volume":"50","author":"Arase","year":"2011","journal-title":"Intern Med"},{"key":"R27-20260520","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2337\/dc13-2704","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes.","volume":"37","author":"Targher","year":"2014","journal-title":"Diabetes Care"},{"key":"R28-20260520","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/ndt\/gfl364","article-title":"Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: the MONICA\/KORA Augsburg Echocardiographic Substudy.","volume":"21","author":"Lieb","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R29-20260520","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.113.003429","article-title":"Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) study.","volume":"129","author":"Katz","year":"2014","journal-title":"Circulation"},{"key":"R30-20260520","doi-asserted-by":"crossref","first-page":"e1840","DOI":"10.1097\/MD.0000000000001840","article-title":"Association between hearing impairment and albuminuria in the Korean adults: the 2011\u20132012 Korea National Health and Nutrition Examination Survey.","volume":"94","author":"Hong","year":"2015","journal-title":"Medicine (Baltim)"},{"key":"R31-20260520","doi-asserted-by":"crossref","first-page":"285","DOI":"10.7150\/ijms.28264","article-title":"Non-alcoholic fatty liver disease is associated with low-grade albuminuria in men without diabetes mellitus.","volume":"16","author":"Kang","year":"2019","journal-title":"Int J Med Sci"},{"key":"R32-20260520","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1053\/j.gastro.2007.03.058","article-title":"The adipocyte as an active participant in energy balance and metabolism.","volume":"132","author":"Badman","year":"2007","journal-title":"Gastroenterology"},{"key":"R33-20260520","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","article-title":"Obesity, inflammation, and insulin resistance.","volume":"132","author":"Shoelson","year":"2007","journal-title":"Gastroenterology"},{"key":"R34-20260520","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jhep.2005.11.030","article-title":"Insulin resistance, adiponectin, cytokines in NASH: which is the best target to treat?","volume":"44","author":"Larter","year":"2006","journal-title":"J Hepatol"},{"key":"R35-20260520","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1681\/ASN.2009080820","article-title":"Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.","volume":"21","author":"Ix","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R36-20260520","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease.","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"R37-20260520","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease.","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"key":"R38-20260520","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R39-20260520","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"key":"R40-20260520","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jhep.2010.11.007","article-title":"Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?","volume":"54","author":"Targher","year":"2011","journal-title":"J Hepatol"},{"key":"R41-20260520","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2012.258","article-title":"The role of hepatokines in metabolism.","volume":"9","author":"Stefan","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"R42-20260520","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/ATVBAHA.114.303034","article-title":"Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease.","volume":"34","author":"Byrne","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R43-20260520","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-0033-1334866","article-title":"Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic\/thrombotic and vascular complications.","volume":"39","author":"Targher","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"R44-20260520","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.","volume":"64","year":"2016","journal-title":"J Hepatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:04:00Z","timestamp":1779275040000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":44,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045270","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2024-11-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}